Page last updated: 2024-09-03

peroxynitrous acid and sanguinarine

peroxynitrous acid has been researched along with sanguinarine in 1 studies

Compound Research Comparison

Studies
(peroxynitrous acid)
Trials
(peroxynitrous acid)
Recent Studies (post-2010)
(peroxynitrous acid)
Studies
(sanguinarine)
Trials
(sanguinarine)
Recent Studies (post-2010) (sanguinarine)
3,303211,23067537290

Protein Interaction Comparison

ProteinTaxonomyperoxynitrous acid (IC50)sanguinarine (IC50)
CholinesteraseHomo sapiens (human)7.08
Nuclear factor NF-kappa-B p105 subunitHomo sapiens (human)2
AcetylcholinesteraseHomo sapiens (human)1.22
Nuclear factor NF-kappa-B p100 subunit Homo sapiens (human)2
Transcription factor p65Homo sapiens (human)2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrekopoulos, C; Huh, J; Kalyanaraman, B; Liepins, A; Sorokin, A; Zielonka, J1

Other Studies

1 other study(ies) available for peroxynitrous acid and sanguinarine

ArticleYear
Cyclooxygenase 2 rescues LNCaP prostate cancer cells from sanguinarine-induced apoptosis by a mechanism involving inhibition of nitric oxide synthase activity.
    Cancer research, 2006, Apr-01, Volume: 66, Issue:7

    Topics: Adenoviridae; Alkaloids; Apoptosis; Benzophenanthridines; Cell Line, Tumor; Cyclooxygenase 2; Epithelial Cells; Gene Transfer Techniques; Humans; Isoquinolines; Male; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Peroxynitrous Acid; Prostatic Neoplasms

2006